Friday 6 November 2026 Export ATRC’s income statement to Excel — free account

AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.

Revenue: +15.0%
EPS: +1,583.9%
Free cash flow: −0.73%
Total debt: −17.3%

Quarter to September 2026, against a year earlier

59.22 2.06 −3.36%

Follow ATRC

Alert me

Market cap: $3.1B
P/E: 199×
Fwd P/E: 573×
Dividend yield: —
F-score: 7/9
Altman Z: 7.31
Beneish M: −2.91
Dividend safety: n/a

Overview

AtriCure, Inc. (ATRC) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a P/S ratio of 5.0×. Over the past ten years it has ranged from 2.2× (August 2024) to 16.8× (June 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ATRC/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AtriCure, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ATRC/metrics/ps-ratio">AtriCure, Inc. (ATRC) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	3.5×	14.57%
FY2024	3.1×	(24.71%)
FY2023	4.1×	(34.01%)
FY2022	6.2×	(45.65%)
FY2021	11.4×	0.59%
FY2020	11.4×	114.46%
FY2019	5.3×	2.35%
FY2018	5.2×	51.09%
FY2017	3.4×	(12.50%)
FY2016	3.9×	(19.37%)

Period	P/S ratio	Change
Sep 2026	4.7×	94.89%
Jun 2026	2.4×	(4.28%)
Mar 2026	2.5×	(29.33%)
Dec 2025	3.5×	8.44%
43 more quarters	Free account

Against its own ten years

Low 2.2× High 16.8×

Ten-year median 4.8×

Current reading's percentile 56

Company	P/S ratio
XRAY DENTSPLY SIRONA Inc. compare	0.6×
NVST Envista Holdings Corporation compare	1.4×
MMED MiniMed Group, Inc. compare	1.7×
ICUI ICU Medical, Inc. compare	1.9×
STVN Stevanato Group S.p.A. compare	2.5×
MMSI Merit Medical Systems, Inc. compare	3.3×
WRBY Warby Parker Inc. compare	3.5×
ATRC AtriCure, Inc.	5.0×
PLSE Pulse Biosciences, Inc compare	2,559×
Medical Instruments & Supplies industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

AtriCure, Inc. (ATRC) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ATRC

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ATRC

Stockrow Weekly